Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 23

1.

[The school doctorand suspected child abuse : towards good practice recommendations in the child's interest].

Noirhomme-Renard F, Blavier A, Lachaussée S, Monville C, Nihoul C, Gosset C.

Rev Med Liege. 2016 Oct;71(10):428-434. Review. French.

PMID:
28383850
2.

Use of human pluripotent stem cells to study and treat retinopathies.

Ben M'Barek K, Regent F, Monville C.

World J Stem Cells. 2015 Apr 26;7(3):596-604. doi: 10.4252/wjsc.v7.i3.596. Review.

3.

Impact of lauric arginate application form on its antimicrobial activity on the surface of a model meat product.

Terjung N, Monville C, Loeffler M, Gibis M, Hinrichs J, Weiss J.

J Food Sci. 2014 Oct;79(10):M2056-65. doi: 10.1111/1750-3841.12641. Epub 2014 Sep 16.

PMID:
25227890
4.

From confluent human iPS cells to self-forming neural retina and retinal pigmented epithelium.

Reichman S, Terray A, Slembrouck A, Nanteau C, Orieux G, Habeler W, Nandrot EF, Sahel JA, Monville C, Goureau O.

Proc Natl Acad Sci U S A. 2014 Jun 10;111(23):8518-23. doi: 10.1073/pnas.1324212111. Epub 2014 May 27.

5.

Human induced pluripotent stem cells as a tool to model a form of Leber congenital amaurosis.

Lustremant C, Habeler W, Plancheron A, Goureau O, Grenot L, de la Grange P, Audo I, Nandrot EF, Monville C.

Cell Reprogram. 2013 Jun;15(3):233-46. doi: 10.1089/cell.2012.0076. Epub 2013 May 10.

PMID:
23663011
6.

Direct myocardial implantation of human embryonic stem cells in a dog model of Duchenne cardiomyopathy reveals poor cell survival in dystrophic tissue.

Habeler W, Ghaleh B, Barthelemy I, Plancheron A, Bizé A, Carlos-Sampedrano C, Chetboul V, Berdeaux A, Pucéat M, Peschanski M, Blot S, Monville C.

J Stem Cells Regen Med. 2011 Oct 30;7(2):80-6. eCollection 2011.

7.

Organotypic heart slices for cell transplantation and physiological studies.

Habeler W, Peschanski M, Monville C.

Organogenesis. 2009 Apr;5(2):62-6.

8.

Genetic, temporal and diurnal influences on L-dopa-induced dyskinesia in the 6-OHDA model.

Monville C, Torres EM, Pekarik V, Lane EL, Dunnett SB.

Brain Res Bull. 2009 Mar 16;78(4-5):248-53. doi: 10.1016/j.brainresbull.2008.11.007. Epub 2008 Dec 12.

PMID:
19070653
9.

An in vitro beating heart model for long-term assessment of experimental therapeutics.

Habeler W, Pouillot S, Plancheron A, Pucéat M, Peschanski M, Monville C.

Cardiovasc Res. 2009 Feb 1;81(2):253-9. doi: 10.1093/cvr/cvn299. Epub 2008 Nov 3.

PMID:
18980954
10.

Improved survival of young donor age dopamine grafts in a rat model of Parkinson's disease.

Torres EM, Monville C, Gates MA, Bagga V, Dunnett SB.

Neuroscience. 2007 Jun 8;146(4):1606-17. Epub 2007 May 2.

PMID:
17478050
11.

Comparison of incremental and accelerating protocols of the rotarod test for the assessment of motor deficits in the 6-OHDA model.

Monville C, Torres EM, Dunnett SB.

J Neurosci Methods. 2006 Dec 15;158(2):219-23. Epub 2006 Jul 11.

PMID:
16837051
13.
14.
15.

Lentivector-mediated delivery of GDNF protects complex motor functions relevant to human Parkinsonism in a rat lesion model.

Dowd E, Monville C, Torres EM, Wong LF, Azzouz M, Mazarakis ND, Dunnett SB.

Eur J Neurosci. 2005 Nov;22(10):2587-95.

PMID:
16307601
16.

In vivo transgene expression from an adenoviral vector is altered following a 6-OHDA lesion of the dopamine system.

Torres EM, Monville C, Lowenstein PR, Castro MG, Dunnett SB.

Brain Res Mol Brain Res. 2005 Jun 13;137(1-2):1-10. Epub 2005 Apr 18.

17.

HSV vector-delivery of GDNF in a rat model of PD: partial efficacy obscured by vector toxicity.

Monville C, Torres E, Thomas E, Scarpini CG, Muhith J, Lewis J, Finn J, Smith C, Cai S, Efstathiou S, Howard K, Dunnett SB.

Brain Res. 2004 Oct 22;1024(1-2):1-15.

PMID:
15451362
18.

Astroglial expression of the P-glycoprotein is controlled by intracellular CNTF.

Monville C, Fages C, Feyens AM, D'Hondt V, Guillet C, Vernallis A, Gascan H, Peschanski M.

BMC Cell Biol. 2002 Jul 31;3:20.

19.

Corticostriatopallidal neuroprotection by adenovirus-mediated ciliary neurotrophic factor gene transfer in a rat model of progressive striatal degeneration.

Mittoux V, Ouary S, Monville C, Lisovoski F, Poyot T, Conde F, Escartin C, Robichon R, Brouillet E, Peschanski M, Hantraye P.

J Neurosci. 2002 Jun 1;22(11):4478-86.

20.

Gene therapy in Parkinson's disease: dream or reality?

Monville C.

Neuroreport. 2002 May 7;13(6):743. No abstract available.

PMID:
12030230

Supplemental Content

Loading ...
Support Center